Kwality Pharmaceuticals (NSE:KPL) Cyclically Adjusted PB Ratio: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KPL Kwality Pharmaceuticals Ltd NSE:KPL
60 GF Score
Price ₹3,630.30
GF Value ₹1,332.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kwality Pharmaceuticals Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kwality Pharmaceuticals  (NSE:KPL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kwality Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Kwality Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Kwality Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kwality Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Kwality Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 4.38 4.46 7.44 8.69

Kwality Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 8.69 0.00

NSE:KPL vs : Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kwality Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kwality Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kwality Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kwality Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


NSE:KPL
60GF Score
Kwality Pharmaceuticals Ltd NSE:KPL
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kwality Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kwality Pharmaceuticals's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar26 is calculated as:

For example, Kwality Pharmaceuticals's adjusted Book Value per Share data for the fiscal year that ended in Mar26 was:

Adj_Book=Book Value per Share/CPI of Mar26 (Change)*Current CPI (Mar26)
=319.579/330.2130*330.2130
=319.579

Current CPI (Mar26) = 330.2130.

Kwality Pharmaceuticals Annual Data

Book Value per Share CPI Adj_Book
201703 49.813 243.801 67.469
201803 28.670 249.554 37.937
201903 35.955 254.202 46.706
202003 44.340 258.115 56.725
202103 58.948 264.877 73.488
202203 174.580 287.504 200.514
202303 193.250 301.836 211.418
202403 216.087 312.332 228.458
202503 254.480 319.799 262.767
202603 319.579 330.213 319.579

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Kwality Pharmaceuticals (NSE:KPL) Overvalued in 2026?

Based on GuruFocus' analysis, Kwality Pharmaceuticals stock appears to be overvalued. The current stock price of ₹3,630.30 is trading 172.5% above its estimated GF Value™ of ₹1,332.01. GuruFocus considers Kwality Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:KPL:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹1,332.01 vs. price of ₹3,630.30 (172.5% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the NSE:KPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kwality Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 539997:India
Address Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.
60GF Score

Get the complete analysis for NSE:KPL

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,630.30
Price
₹1,332.01
GF Value